2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Solid Tumors: Breast, Lung, Colorectal, Prostate, Pancreatic, Liver, Ovarian
Solid tumors encompass a diverse range of cancers affecting specific organs and tissues. Breast and prostate cancers are highly prevalent, with ongoing advancements in targeted therapies and hormonal treatments improving patient outcomes. Lung cancer research focuses on personalized medicine, utilizing biomarkers to tailor treatments. Colorectal cancer studies emphasize the role of gut microbiota and immunotherapy in disease progression and treatment. Pancreatic cancer remains one of the most lethal forms, with efforts directed toward early detection and innovative therapies. Liver cancer research highlights the significance of antiviral treatments in hepatitis-associated cases. Ovarian cancer advancements include precision surgery and novel chemotherapy regimens. These research areas collectively aim to enhance survival rates and improve the quality of life for cancer patients.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China